Inflammatory bowel disease and inflammatory molecules: Chickens, eggs and therapeutic targets

作者
Michael Grimm
出处
期刊:Journal of Gastroenterology and Hepatology [Wiley]
卷期号:17 (9): 935-937 被引量:1
标识
DOI:10.1046/j.1440-1746.2002.02771.x
摘要

See article in volume 16, issue 11, pages 1228–1234 The gastrointestinal immune system is the largest collection of immune cells in the body. It is juxtaposed between the hostile external environment of the gut and the benign internal milieu that it protects. It deals with a vast array of luminal antigens in the form of food and bacteria in a unique, underplayed fashion. The immunity thereby generated is distinct in its nature and outcome from the systemic variety that we usually think of when we consider antigen-driven responses. The characteristic appearance of the normal intestine, unlike other unperturbed tissues, is one of controlled inflammation.1 What is most remarkable about this, however, is that full-blown inflammatory bowel disease (IBD) is as uncommon as it is. This is related to constitutive, active downregulation of both the innate immune system2 and antigen-specific immunity3 in the gut. Our understanding of the immunopathogenesis of IBD has advanced immensely over the last decade. A large number of inflammatory mediators present in excess in IBD tissues have been characterized. This has made it possible to successfully introduce specific, biologically directed therapies, such as monoclonal antibodies against tumor necrosis factor-α in Crohn's disease.4 An immunologist's dream of novel therapies is in the wings, in phase II and III trials. Indeed, so-called non-specific therapies including corticosteroids and aminosalicylates also target different molecules and pathways in the inflammatory cascade. Most of these inflammatory mediators are probably upregulated in response to the phlogistic environment in which they are expressed. Nevertheless, the efficacy of therapies directed against them indicates that, analagous to peptic ulcer disease before the discovery of Helicobacter pylori, targeting a final common pathway can be an effective approach to treatment of diseases of unknown etiology. A causative inflammatory defect in IBD is suggested by the nature of the newly described gene mutated in a proportion of familial and sporadic Crohn's disease patients.5–7Nod2 is a monocyte-specific signaling molecule in the nuclear factor-κB activation pathway that binds lipopolysaccharide, an essential constituent of the cell wall of Gram-negative bacteria, as well as other bacterial products.8 The mechanism by which this defect causes Crohn's disease is uncertain but it is presumably related to either a defect in innate immune response to gut bacteria,9 or to an abnormality in apoptosis regulation.5,10 This is an exciting discovery because it will allow dissection of interactions between bacteria, innate immunity and IBD, as well as direct exploration of other candidate genes in both familial and sporadic IBD. In addition to defects in innate immunity, there is also powerful evidence that IBD is dependent on antigen-driven immunity gone awry. The immune outcome of tolerance, which distinguishes the usual response to gut bacteria, is lost in IBD and is typically replaced by a polarized, T-helper type 1 (Th1) immune response and accumulation of activated CD4+ T cells. Th1 cytokines including interleukin (IL)-12 and γ-interferon are prominent in human IBD tissues11 and are the focus of therapeutic trials of anti-IL-12 antibodies currently underway. Animal models of IBD provide the best evidence for an antigen-dependent pathway to inflammation: virtually all of the many models of IBD rely on population of the intestine by normal flora, with no inflammation seen in germ-free mice. In fact, reintroduction of isolated strains of bacteria to the intestine of germ-free mice recapitulates the inflammation seen in normally colonized animals. Further evidence for a requirement for T-cell-dependent antigen recognition comes from a number of genetically altered mice which spontaneously develop colitis. These include animals that express defective T cell receptors (TCR)12 or have aberrant post-TCR signaling,13 and immunodeficient mice reconstituted with effector T cells.14 For productive T-cell activation to occur in response to antigen recognition, TCR signaling must be accompanied by ligation of costimulatory molecules on the surface of antigen-presenting cells and T cells. One such group of costimulatory molecules is the B7 family of peptides, found on antigen-presenting cells.15 These costimulatory molecules most commonly ‘meet’ CD28 on the T cell, although other interactions can also occur. Grose et al. in a previous issue of the Journal, highlight the potential involvement of the B7 molecules, CD80 and CD86, in the colitis lesions induced in mice that have ingested dextran sulfate sodium (DSS).16 Dextran sulfate sodium induces an acute colitis with epithelial ulceration, reminiscent of ulcerative colitis in humans. It is a model that has been used to study acute inflammatory events as well as later, more chronic changes such as dysplasia and carcinoma.17 It is probably dependent on macrophage ingestion of DSS, followed by macrophage activation, tissue destruction and subsequent T-cell activation. The paper by Grose et al. examines the expression of CD80 and CD86, using immunofluorescence staining, in the DSS-induced lesions.16 It demonstrates a markedly heightened display that occurs several days after the onset of severe inflammation and it implies that this expression is by upregulation on infiltrating macrophages and, to a lesser degree, on B cells. Somewhat surprisingly, dendritic cells, the classical antigen-presenting cells most capable of activating T cells, were not seen in these tissues and Grose et al. speculate that infiltrating macrophages are induced to become the chief antigen-presenting cells in this colitis model. The findings presented bear some similarities to earlier demonstrations of B7 family expression in human IBD,18,19 and in another murine model of colitis.20 The authors speculate that CD80 and CD86 may therefore become novel therapeutic targets in the search for specific anti-IBD agents, although recent data indicate that interfering with costimulatory molecules might simply shift the target tissue for autoimmune processes.21 There are, of course, unanswered questions, for example: how important is antigen presentation in the lamina propria of the colon? How much occurs in regional (mesenteric) lymph nodes and are different antigen-presenting cells responsible in that site? What of ‘immunosuppressive’ B7 interactions with the alternative ligand, the T-cell molecule CTLA-4, that might already be applying a brake on the inflammatory process? What is the likely pathogenetic role of B7 molecules that appear to be expressed as a secondary phenomenon? How likely to reduce inflammation is inhibition of molecules that are only seen at the height of inflammation? How accurately does DSS colitis mirror human ulcerative colitis anyway? For each incremental step in elucidating the chicken and egg pathways to inflammation in IBD, there are numerous unanswered questions. Some of these questions will be answered by grasping the nettle, and establishing biologically dictated therapeutic trials. Grose et al. have highlighted a few more questions; one way or another, the answers will arrive.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
今后的应助被xiang采纳,获得20
刚刚
KP完成签到,获得积分10
刚刚
aaaaa发布了新的文献求助10
刚刚
我是老大的应助被Rony采纳,获得10
刚刚
dildil发布了新的文献求助10
1秒前
1秒前
Ava的应助被Chelseacyh采纳,获得10
2秒前
2秒前
2秒前
3秒前
3秒前
dd完成签到,获得积分10
4秒前
Dc完成签到,获得积分10
4秒前
李健的应助被小马采纳,获得10
4秒前
JackieLiu的应助被默默惜霜采纳,获得10
4秒前
科研通AI6.2的应助被默默惜霜采纳,获得10
4秒前
ephemeral发布了新的文献求助10
4秒前
元吉的应助被默默惜霜采纳,获得10
4秒前
秋风的应助被默默惜霜采纳,获得10
5秒前
5秒前
小蘑菇的应助被勤恳的小甜瓜采纳,获得10
5秒前
5秒前
5秒前
自己完成签到,获得积分10
6秒前
科研小趴菜完成签到,获得积分10
6秒前
耍酷季节的应助被IY采纳,获得30
6秒前
7秒前
领导范儿的应助被钦钦小豆包采纳,获得10
8秒前
H11103y发布了新的文献求助10
8秒前
钟梓袄发布了新的文献求助10
8秒前
9秒前
hhh完成签到,获得积分10
10秒前
天天快乐的应助被Present采纳,获得10
10秒前
李健的应助被田浩阳采纳,获得10
10秒前
10秒前
10秒前
顺利毕业发布了新的文献求助10
11秒前
11秒前
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183204
求助须知:如何正确求助?哪些是违规求助? 9572434
关于积分的说明 21825655
捐赠科研通 7779988
什么是DOI,文献DOI怎么找? 3433852
关于科研通互助平台的介绍 2558060
邀请新用户注册赠送积分活动 2480148